Denali Therapeutics Inc.
DNLI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001714899
In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Denali Therapeutics Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 190 | 4 | 188 | +2 |
| Shares | 86.8M | 228.5K | 92.7M | +6.15M (+7.1%) |
| Value | $2.79B | $7.35M | $2.73B | −$55.8M (−2.0%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Denali Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARCH Venture Management, LLC | 5,168,749 | $152.1M | 18.54% |
| Millennium Management LLC | 645,336 | $19.0M | 0.02% |
| Alps Advisors Inc | 72,940 | $2.15M | 0.02% |
| ExodusPoint Capital Management, LP | 64,187 | $1.89M | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 35,234 | $1.04M | 0.00% |
| HRT Financial LP | 23,600 | $694.0K | 0.01% |
| Delphia (USA) Inc. | 17,586 | $518.0K | 0.36% |
| Tudor Investment Corp Et Al | 16,464 | $485.0K | 0.01% |
| Corton Capital Inc. | 15,973 | $470.0K | 0.44% |
| Gotham Asset Management, LLC | 15,285 | $450.0K | 0.01% |
| Jump Financial, LLC | 14,297 | $420.0K | 0.02% |
| Jane Street Group, LLC | 13,923 | $410.0K | 0.00% |
| Occudo Quantitative Strategies LP | 10,672 | $314.0K | 0.03% |
| Fred Alger Management, LLC | 8,983 | $264.0K | 0.00% |
| Mackenzie Financial Corp | 6,898 | $203.0K | 0.00% |
| Lazard Asset Management LLC | 5,353 | $157.0K | 0.00% |
| Levin Capital Strategies, L.P. | 2,500 | $74.0K | 0.01% |
| Hoey Investments, Inc | 100 | $3.00K | 0.00% |
| CWM, LLC | 69 | $2.00K | 0.00% |
| Bell Investment Advisors, Inc | 64 | $2.00K | 0.00% |
| Allworth Financial LP | 8 | $0 | 0.00% |
Sold out (19)
Institutions that held Denali Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Squarepoint Ops LLC | 34,435 | $1.11M |
| Duality Advisers, LP | 34,200 | $1.10M |
| Walleye Capital LLC | 28,296 | $910.0K |
| Integral Health Asset Management, LLC | 26,000 | $836.0K |
| Eaton Vance Management | 23,057 | $742.0K |
| AQR Capital Management LLC | 22,686 | $730.0K |
| Twinbeech Capital LP | 18,046 | $581.0K |
| Algert Global LLC | 15,203 | $489.0K |
| First Trust Advisors LP | 14,224 | $458.0K |
| Capital Fund Management S.A. | 13,443 | $432.5K |
| Gsa Capital Partners LLP | 6,940 | $223.0K |
| Ergoteles LLC | 6,693 | $215.0K |
| Point72 Hong Kong Ltd | 1,194 | $38.0K |
| Aquatic Capital Management LLC | 1,100 | $35.0K |
| EverSource Wealth Advisors, LLC | 51 | $2.00K |
| Massmutual Trust Co FSB | 26 | $1.00K |
| TCWP LLC | 34 | $1.00K |
| Ci Investments Inc. | 4 | $0 |
| Ellevest, Inc. | 3 | $0 |
Not filed for Q2 2022 yet (4)
Institutions that held Denali Therapeutics Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Teachers Retirement System of the State of Kentucky | 171,496 | $5.52M |
| Parametric Portfolio Associates LLC | 27,557 | $887.0K |
| Amalgamated Financial Corp. | 14,893 | $479.0K |
| Virginia Retirement Systems Et Al | 14,600 | $470.0K |